Single institution prescribing pattern of finerenone in patients with type 2 diabetes and/or chronic kidney disease in the USA

被引:3
作者
Zhang, Rong M. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63130 USA
关键词
D O I
10.1093/ckj/sfad073
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1538 / 1539
页数:2
相关论文
共 1 条
[1]   Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes [J].
Lerma, Edgar V. ;
Wilson, Daniel J. .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (05) :501-513